PCSA 8-K/A 2026-10-05

Processa Pharmaceuticals, Inc. (PCSA) 8-K/A dated 2026-10-05 — accession 0001140361-26-038535. This URL is the filing, not the PCSA hub.

Processa Pharmaceuticals, Inc. (PCSA) is a biotechnology company listed on NASDAQ.

Processa Pharmaceuticals, Inc. filed a 8-K/A on 2026-10-05. Accession 0001140361-26-038535.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported PCSA revenue for 2022-12-31 was $0. Net income was -$27.4M. PCSA currently screens at market cap $5.9M.

Not investment advice. The PCSA SEC hub lists recent forms. The stock page is the research view.